Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice

INTRODUCTION: Treatment-free remission (TFR) is a new goal of chronic myeloid leukemia (CML) therapy. TFR is feasible when the patient has achieved a deep and stable molecular response and met the criteria required to ensure its success. Treatment discontinuation should not be proposed to the CML pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Boquimpani, Carla, Seguro, Fernanda Salles, Magalhães, Gustavo Henrique Romani, Pinto, Ingrid Luise Soares, Bendit, Israel, Bortolini, Jaisson André Pagnoncelli, Pagnano, Katia Borgia Barbosa, Centrone, Renato, Funke, Vaneuza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477780/
https://www.ncbi.nlm.nih.gov/pubmed/35654721
http://dx.doi.org/10.1016/j.htct.2022.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477780/
https://www.ncbi.nlm.nih.gov/pubmed/35654721
http://dx.doi.org/10.1016/j.htct.2022.04.002

Ejemplares similares